Negative  ||| S:0 E:9 ||| JJ
pressure  ||| S:9 E:18 ||| NN
therapy-  ||| S:18 E:27 ||| JJ
supportive  ||| S:27 E:38 ||| JJ
method  ||| S:38 E:45 ||| NN
in  ||| S:45 E:48 ||| IN
chronic  ||| S:48 E:56 ||| JJ
wound  ||| S:56 E:62 ||| NN
treatment  ||| S:62 E:72 ||| NN
Negative  ||| S:72 E:81 ||| JJ
pressure  ||| S:81 E:90 ||| NN
sound  ||| S:90 E:96 ||| NN
therapy  ||| S:96 E:104 ||| NN
is  ||| S:104 E:107 ||| VBZ
one  ||| S:107 E:111 ||| CD
of  ||| S:111 E:114 ||| IN
the  ||| S:114 E:118 ||| DT
supportive  ||| S:118 E:129 ||| JJ
options  ||| S:129 E:137 ||| NNS
for  ||| S:137 E:141 ||| IN
chronic  ||| S:141 E:149 ||| JJ
wound  ||| S:149 E:155 ||| NN
treatment ||| S:155 E:164 ||| NN
.  ||| S:164 E:166 ||| .
Good  ||| S:166 E:171 ||| JJ
results  ||| S:171 E:179 ||| NNS
have  ||| S:179 E:184 ||| VBP
been  ||| S:184 E:189 ||| VBN
reported  ||| S:189 E:198 ||| VBN
in  ||| S:198 E:201 ||| IN
increasing  ||| S:201 E:212 ||| VBG
angiogenesis ||| S:212 E:224 ||| NN
,  ||| S:224 E:226 ||| ,
improving  ||| S:226 E:236 ||| VBG
blood  ||| S:236 E:242 ||| NN
flow  ||| S:242 E:247 ||| NN
in  ||| S:247 E:250 ||| IN
the  ||| S:250 E:254 ||| DT
wounds ||| S:254 E:260 ||| NNS
,  ||| S:260 E:262 ||| ,
decreasing  ||| S:262 E:273 ||| VBG
edema ||| S:273 E:278 ||| NN
,  ||| S:278 E:280 ||| ,
regulating  ||| S:280 E:291 ||| VBG
moist  ||| S:291 E:297 ||| JJ
environment ||| S:297 E:308 ||| NN
,  ||| S:308 E:310 ||| ,
granulation  ||| S:310 E:322 ||| JJ
tissue  ||| S:322 E:329 ||| NN
stimulation  ||| S:329 E:341 ||| NN
and  ||| S:341 E:345 ||| CC
wound  ||| S:345 E:351 ||| JJ
retraction ||| S:351 E:361 ||| NN
.  ||| S:361 E:363 ||| .
In  ||| S:363 E:366 ||| IN
addition ||| S:366 E:374 ||| NN
,  ||| S:374 E:376 ||| ,
there  ||| S:376 E:382 ||| EX
is  ||| S:382 E:385 ||| VBZ
significant  ||| S:385 E:397 ||| JJ
reduction  ||| S:397 E:407 ||| NN
in  ||| S:407 E:410 ||| IN
bacterial  ||| S:410 E:420 ||| JJ
burden  ||| S:420 E:427 ||| NN
and  ||| S:427 E:431 ||| CC
in  ||| S:431 E:434 ||| IN
the  ||| S:434 E:438 ||| DT
amount  ||| S:438 E:445 ||| NN
of  ||| S:445 E:448 ||| IN
harmful  ||| S:448 E:456 ||| JJ
products  ||| S:456 E:465 ||| NNS
( ||| S:465 E:466 ||| -LRB-
exotoxins ||| S:466 E:475 ||| UH
,  ||| S:475 E:477 ||| ,
endotoxins ||| S:477 E:487 ||| NN
,  ||| S:487 E:489 ||| ,
cytokines  ||| S:489 E:499 ||| NN
and  ||| S:499 E:503 ||| CC
matrix  ||| S:503 E:510 ||| JJ
metalloproteinases ||| S:510 E:528 ||| NN
)  ||| S:528 E:530 ||| -RRB-
in  ||| S:530 E:533 ||| IN
the  ||| S:533 E:537 ||| DT
wound ||| S:537 E:542 ||| NN
.  ||| S:542 E:544 ||| .
The  ||| S:544 E:548 ||| DT
healing  ||| S:548 E:556 ||| NN
time  ||| S:556 E:561 ||| NN
for  ||| S:561 E:565 ||| IN
chronic  ||| S:565 E:573 ||| JJ
wounds  ||| S:573 E:580 ||| NNS
is  ||| S:580 E:583 ||| VBZ
reduced  ||| S:583 E:591 ||| VBN
in  ||| S:591 E:594 ||| IN
comparison  ||| S:594 E:605 ||| NN
with  ||| S:605 E:610 ||| IN
other  ||| S:610 E:616 ||| JJ
conservative  ||| S:616 E:629 ||| JJ
treatments ||| S:629 E:639 ||| NNS
.  ||| S:639 E:641 ||| .
